150 results
DEFA14A
PVCT
Provectus Biopharmaceuticals, Inc.
20 Jun 24
Additional proxy soliciting materials
6:03am
in this press release may include “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, relating
8-K
EX-10.2
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
, then the prevailing party in any litigation instituted to enforce such breach shall have the right to recover from the losing party its costs related thereto
8-K
EX-10.1
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
appropriate remedy to enforce performance of such agreements. In the event of a breach of this Agreement, then the prevailing party in any litigation
8-K
EX-10.1
hungwip
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
EX-10.2
mgphy3b9g7p0k
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
EX-99.1
tyi2w oc71xrrj6o
15 Feb 24
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
8:05am
8-K
EX-4.1
kknj5
26 Sep 22
Entry into a Material Definitive Agreement
1:45pm
8-K
EX-4.1
y53oh c62qnn
18 Aug 21
Entry into a Material Definitive Agreement
8:27am